{"chunk_type":"transcript_chunk","text":"---\n### ğŸŒ³ Top-down Classification: Joint Pain\nì´ ê°•ì˜ëŠ” **Joint Pain**ì´ë¼ëŠ” ê±°ëŒ€í•œ ìˆ²ì—ì„œ ì‹œì‘í•˜ì—¬, ì—¼ì¦ì„±(Inflammatory)ì¸ì§€ ë¹„ì—¼ì¦ì„±(Non-inflammatory)ì¸ì§€, ê·¸ë¦¬ê³  ë‹¨ê´€ì ˆ(Mono)ì¸ì§€ ë‹¤ê´€ì ˆ(Poly)ì¸ì§€ë¥¼ êµ¬ë¶„í•´ ë‚˜ê°€ëŠ” ê³¼ì •ì…ë‹ˆë‹¤.\nPlaintext\n`JOINT PAIN (The Big Picture)\nâ”‚\nâ”œâ”€â”€ Monoarthritis (ë‹¨ê´€ì ˆì—¼: 1 Joint, Red, Hot, Swollen)\nâ”‚   â”œâ”€â”€ EMERGENCY (ë†“ì¹˜ë©´ ê´€ì ˆ íŒŒê´´/ì‚¬ë§)\nâ”‚   â”‚   â””â”€â”€ Septic Arthritis (Infection) ğŸš¨\nâ”‚   â”‚       â”œâ”€â”€ Adult: Staph aureus (MC)\nâ”‚   â”‚       â”œâ”€â”€ Young/Sexually Active: N. gonorrhoeae (DGI)\nâ”‚   â”‚       â””â”€â”€ Pediatric: Hip/Knee (Kocher Criteria)\nâ”‚   â”‚\nâ”‚   â”œâ”€â”€ Crystal Arthropathies (Inflammatory)\nâ”‚   â”‚   â”œâ”€â”€ Gout (MSU crystals)\nâ”‚   â”‚   â””â”€â”€ Pseudogout (CPPD crystals)\nâ”‚   â”‚\nâ”‚   â””â”€â”€ Trauma / Structural\nâ”‚       â”œâ”€â”€ Fight Bite (Eikenella corrodens) ğŸ¥Š\nâ”‚       â””â”€â”€ Hemarthrosis\nâ”‚\nâ”œâ”€â”€ Polyarthritis (ë‹¤ê´€ì ˆì—¼)\nâ”‚   â”œâ”€â”€ Non-Inflammatory (Mechanical)\nâ”‚   â”‚   â””â”€â”€ Osteoarthritis (OA) - Wear & Tear + Metabolic âš™ï¸\nâ”‚   â”‚\nâ”‚   â”œâ”€â”€ Inflammatory (Systemic)\nâ”‚   â”‚   â”œâ”€â”€ Rheumatoid Arthritis (RA)\nâ”‚   â”‚   â”œâ”€â”€ Spondyloarthropathies (Seronegative)\nâ”‚   â”‚   â”‚   â”œâ”€â”€ Ankylosing Spondylitis (Bamboo Spine) ğŸ‹\nâ”‚   â”‚   â”‚   â”œâ”€â”€ Reactive Arthritis (Reiter's)\nâ”‚   â”‚   â”‚   â”œâ”€â”€ Psoriatic Arthritis\nâ”‚   â”‚   â”‚   â””â”€â”€ IBD-associated\nâ”‚   â”‚   â”‚\nâ”‚   â”‚   â””â”€â”€ Vasculitis / Systemic\nâ”‚   â”‚       â”œâ”€â”€ Henoch-Schonlein Purpura (HSP) - IgA\nâ”‚   â”‚       â””â”€â”€ Cryoglobulinemia (Hep C assoc.)\nâ”‚   â”‚\nâ”‚   â””â”€â”€ Others\nâ”‚       â”œâ”€â”€ TMJ Dysfunction ğŸ¦·\nâ”‚       â””â”€â”€ Hemochromatosis (Hook-like osteophytes)\nâ”‚\nâ””â”€â”€ Synovial Fluid Analysis (The Golden Key ğŸ”‘)\n    â”œâ”€â”€ Normal: < 200 WBCs\n    â”œâ”€â”€ Non-inflammatory (OA): 200 - 2,000 WBCs\n    â”œâ”€â”€ Inflammatory (Gout/RA): 2,000 - 50,000 WBCs\n    â””â”€â”€ Septic (Infection): > 50,000 WBCs (Neutrophils > 90%) ğŸ’£`\n---\n# [Ep 01] Joint Pain Deep Dive ğŸ¤¿\n## 1.0 The Healthy Joint: An Engineering Marvel ğŸ¦´\n- **Concept:** ê±´ê°•í•œ ê´€ì ˆì€ \"ì–¼ìŒ ìœ„ì˜ ì–¼ìŒ(Ice on Ice)\"ë³´ë‹¤ ë§ˆì°°ê³„ìˆ˜ê°€ ë‚®ìŠµë‹ˆë‹¤.\n- **Structure:** Articular cartilage + Synovial fluidê°€ ì™„ë²½í•œ ìœ¤í™œìœ  ì—­í• ì„ í•˜ì—¬ ë§ˆì°°ì´ ê±°ì˜ 0ì— ê°€ê¹ìŠµë‹ˆë‹¤.\n- **Pathology:** ì´ ê¸°ê³„ì¥ì¹˜ê°€ ê³ ì¥ ë‚˜ë©´ ë”ì°í•œ ì¼ì´ ë°œìƒí•©ë‹ˆë‹¤. ë‹¨ìˆœí•œ í†µì¦(Ache)ì´ ì•„ë‹ˆë¼ ê¸°ê³„ì  ë¶•ê´´(Breakdown)ë¥¼ ì˜ë¯¸í•©ë‹ˆë‹¤.\n---\n## 2.0 Septic Arthritis (The Emergency) ğŸš¨\n**\"Never let the sun set on a Septic Joint.\"** (ì ˆëŒ€ í•´ê°€ ì§€ê²Œ ë‘ì§€ ë§ˆë¼. ì¦‰, ì¦‰ì‹œ í•´ê²°í•´ë¼!)\n### ğŸšª Doorway Thought (Vignette)\n- **Scenario:** ER ë¬¸ì„ ì—´ì—ˆì„ ë•Œ, í™˜ìê°€ ë¬´ë¦(ë˜ëŠ” ê³ ê´€ì ˆ)ì„ ë¶€ì—¬ì¡ê³  **ì ˆëŒ€ ì›€ì§ì´ë ¤ í•˜ì§€ ì•ŠìŒ(Refusal to move)**.\n- **Key Sign:** Active motion ë¿ë§Œ ì•„ë‹ˆë¼ **Passive motion** (ì˜ì‚¬ê°€ ë‹¤ë¦¬ë¥¼ ë“¤ì–´ ì˜¬ë¦¬ë ¤ í•  ë•Œ)ì—ë„ ìì§€ëŸ¬ì§€ëŠ” ë¹„ëª…ì„ ì§€ë¦„.\n- **Visual:** Red, Hot, Swollen Joint (Monoarticular).\n### ğŸ©º Diagnosis & Workup\n- **Gold Standard:** **Arthrocentesis (Joint Aspiration)**. ë°”ëŠ˜ ê½‚ì•„ì„œ ë¬¼ ë½‘ì•„ì•¼ í•©ë‹ˆë‹¤! â˜…\n    - **The Magic Number:** **WBC > 50,000/mm3** (Neutrophils > 90%)\n    - *Caveat:* ë¥˜ë§ˆí‹°ìŠ¤ ê´€ì ˆì—¼(RA)ì´ë‚˜ í†µí’(Gout) ë°œì‘ ì‹œì—ë„ 50k ê·¼ì²˜ê¹Œì§€ ê°ˆ ìˆ˜ ìˆì§€ë§Œ, 50kê°€ ë„˜ìœ¼ë©´ ì¼ë‹¨ **Septic**ìœ¼ë¡œ ê°„ì£¼í•˜ê³  ì¹˜ë£Œí•´ì•¼ í•¨.\n- **Mechanism:** ë°±í˜ˆêµ¬(Neutrophil)ê°€ ë°•í…Œë¦¬ì•„ë¥¼ ì£½ì´ë ¤ê³  íš¨ì†Œ(Proteolytic enzymes)ë¥¼ ë¿œì–´ë‚´ëŠ”ë°, ì´ê²Œ ë°•í…Œë¦¬ì•„ë§Œ ì£½ì´ëŠ” ê²Œ ì•„ë‹ˆë¼ **ì—°ê³¨(Cartilage)ë„ ë…¹ì—¬ë²„ë¦¼**.\n    - **Time limit:** 24~48ì‹œê°„ ì•ˆì— ê´€ì ˆì´ ì˜êµ¬ì ìœ¼ë¡œ íŒŒê´´ë  ìˆ˜ ìˆìŒ.\n### ğŸ’Š Management (Next Best Step)\n1. **Tap the Joint (Aspiration):** ì§„ë‹¨ ë° ì••ë ¥ í•´ì†Œ(Pain relief).\n2. **Antibiotics:** ì¦‰ì‹œ ì‹œì‘ (Empiric).\n    - Adult: **Vancomycin + Ceftriaxone** (Staph aureus & Gram negatives ì»¤ë²„).\n3. **Surgical Drainage (Washout):** ê³ ë¦„(Pus)ì„ ì”»ì–´ë‚´ì•¼ í•¨. \"Drain the abscess.\"\n### ğŸ‘¶ Pediatric Considerations (The Limping Child)\n- **Vignette:** 2ì„¸ ì•„ì´ê°€ ë‹¤ë¦¬ë¥¼ ì ˆê±°ë‚˜(Limping), ì•„ì˜ˆ ê¸°ì–´ ë‹¤ë‹ˆì§€ ì•Šìœ¼ë ¤ í•¨(Refuses to crawl).\n- **Differential:** Septic Arthritis vs **Transient Synovitis** (ì¼ê³¼ì„± í™œë§‰ì—¼ - \"Hipì˜ ê°ê¸°\").\n    - Transient Synovitis: ë°”ì´ëŸ¬ìŠ¤ ê°ì—¼ í›„ ë°œìƒ, ì €ì ˆë¡œ ì¢‹ì•„ì§ (Benign).\n- **Kocher Criteria (Septic Hip ê°ë³„ë²•) â˜…:**\n    1. **Non-weight bearing:** ì•„ì˜ˆ ê±·ì§€ ëª»í•¨.\n    2. **Fever:** > 38.5Â°C (101.3Â°F).\n    3. **ESR:** > 40 mm/hr.\n    4. **WBC:** > 12,000 (Serum).\n    - *Probability:* 4ê°œ ë‹¤ ìˆìœ¼ë©´ 99% Septic Arthritis â†’ **OR(ìˆ˜ìˆ ì‹¤)ë¡œ ì§í–‰**.\n- Diagnosis is unclear â†’ **bilateral hip sonography**\n    - Even if ì¦ìƒì´ í•œìª½ì— ìˆì–´ë„ ì–‘ìª½ì— fluid in the both hips in Transient synovitis\n    - ì¦ìƒì´ í•œìª½ì—ë§Œ ìˆìœ¼ë©´ â†’ septic arthritis í™•ë¥  ì˜¬ë¼ê° â†’ diagnostic arthocentesis","subject":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","page_title":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","episode":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","section_path":["LM_OSRHM 30046f2986ee8098921dc4e04b63ee22"],"source_doc_id":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","source_page":null,"source_anchor":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22-41","focus_area":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"---\n## 3.0 Fight Bite (Clenched Fist Injury) ğŸ¥Š\n**\"The Lie in the History.\"** í™˜ìëŠ” ê±°ì§“ë§ì„ í•©ë‹ˆë‹¤.\n### ğŸšª Doorway Thought\n- **Scenario:** ë‚¨ìê°€ ì†ë“±(Knuckle, MCP joint)ì— ì‘ì€ ìƒì²˜(Laceration)ë¥¼ ì…ê³  ì˜´. \"ì„¤ê±°ì§€í•˜ë‹¤ ë² ì˜€ì–´ìš”\" í˜¹ì€ \"ë„˜ì–´ì¡Œì–´ìš”\"ë¼ê³  í•¨.\n- **Truth:** ëˆ„êµ°ê°€ì˜ **ì´ë¹¨(Tooth)**ì„ ì£¼ë¨¹ìœ¼ë¡œ ë•Œë¦° ê²ƒì„. (Human Bite).\n### ğŸ¦  Pathophysiology\n- **Anatomy:** ì£¼ë¨¹ì„ ì¥ì—ˆì„ ë•Œ(Fist), í˜ì¤„(Extensor tendon)ê³¼ í”¼ë¶€ê°€ íŒ½íŒ½í•˜ê²Œ ë‹¹ê²¨ì§ â†’ ì´ë¹¨ì´ ëš«ê³  ë“¤ì–´ê° â†’ ê´€ì ˆë‚­(Joint capsule)ì— ê·  ì£¼ì….\n- **The Trap:** ì†ì„ í´ë©´(Relax), í˜ì¤„ê³¼ í”¼ë¶€ê°€ ë¯¸ë„ëŸ¬ì ¸ ì œìë¦¬ë¡œ ëŒì•„ì˜¤ë©´ì„œ **êµ¬ë©ì´ ì–´ê¸‹ë‚¨ (Sliding Door effect)**.\n    - ê²°ê³¼: ê· ì´ ê¹Šìˆ™í•œ ê³³(í˜ê¸°ì„± í™˜ê²½)ì— ê°‡í˜€ë²„ë¦¼. ğŸ¦ ğŸ”’\n- **Bug:** **Eikenella corrodens** (Human mouth flora, Anaerobe) + Staph/Strep. \"Poly-microbial party.\"\n### ğŸš« Management Rules\n- **Absolute Rule:** **NEVER SUTURE (ì ˆëŒ€ ë´‰í•© ê¸ˆì§€).** ğŸ§µâŒ\n    - ë´‰í•©í•˜ë©´ ë†ì–‘(Abscess)ì„ ë°€ë´‰í•´ë²„ë¦¬ëŠ” ê¼´.\n- **Treatment:**\n    1. **Irrigation & Debridement:** ì”»ì–´ë‚´ê³  ì£½ì€ ì¡°ì§ ì œê±°.\n    2. **Antibiotics:** **Amoxicillin-Clavulanate (Augmentin)** (PO) or **Ampicillin-Sulbactam (Unasyn)** (IV).\n    3. **Secondary Intention:** ìƒì²˜ê°€ ì—´ë¦° ì±„ë¡œ ì•„ë¬¼ê²Œ ë‘ .\n---\n## 4.0 Disseminated Gonococcal Infection (DGI) ğŸ†ğŸ”¥\n- *\"Sexually Active Young Adult\"**ì˜ ë‹¨ê´€ì ˆì—¼ ì›ì¸ 1ìˆœìœ„.\n### ğŸšª Doorway Thought\n- **Presentation 1:** Purulent Monoarthritis (Septic Kneeì²˜ëŸ¼ ë³´ì„).\n- **Presentation 2 (The Triad):**\n    1. **Tenosynovitis:** ì†ëª©, ë°œëª© í˜ì¤„ì˜ ì—¼ì¦/í†µì¦.\n    2. **Dermatitis:** Pustules (ê³ ë¦„ì§‘) on extremities (íŒ”ë‹¤ë¦¬ì— ë“œë¬¸ë“œë¬¸ ë‚œ ì—¬ë“œë¦„ ê°™ì€ ê²ƒ).\n    3. **Migratory Polyarthralgia:** ì—¬ê¸°ì €ê¸° ê´€ì ˆì´ ëŒì•„ê°€ë©° ì•„í””.\n### ğŸ•µï¸ Diagnosis Dilemma\n- **Trap:** ë¬´ë¦ì—ì„œ ë¬¼ì„ ë½‘ì•„ë„ ë°°ì–‘(Culture)ì´ **ìŒì„±(Negative)**ì¸ ê²½ìš°ê°€ ë§ìŒ. (ê· ì´ ê¹Œë‹¤ë¡œì›€ - Fastidious).\n- **Gold Standard:** **NAAT (Nucleic Acid Amplification Test)**.\n    - **Tip:** ë¬´ë¦ë§Œ ì°Œë¥´ì§€ ë§ê³ , **Urethra (ìš”ë„), Rectum (í•­ë¬¸), Pharynx (ëª©êµ¬ë©)** ë“± ê· ì´ ë“¤ì–´ì™”ì„ ë²•í•œ ëª¨ë“  ì…êµ¬ë¥¼ ë‹¤ ê¸ì–´ì•¼ í•¨(Swab).\n### ğŸ’Š Treatment\n- **IV Ceftriaxone** (Gonorrhea) + **Azithromycin or Doxycycline** (Chlamydia Co-infection ì»¤ë²„).\n---\n## 5.0 Osteoarthritis (OA) ğŸ‘µâš™ï¸","subject":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","page_title":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","episode":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","section_path":["LM_OSRHM 30046f2986ee8098921dc4e04b63ee22"],"source_doc_id":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","source_page":null,"source_anchor":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22-61","focus_area":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"**\"Wear and Tear... and Repair?\"**\n### ğŸšª Doorway Thought\n- **Patient:** 40ëŒ€ ì´ìƒ (ë‚˜ì´ ë“¦).\n- **Symptom:** **Pain worse with use**, better with rest. (ì“°ë©´ ì•„í”„ê³  ì‰¬ë©´ ë‚«ë‹¤).\n- **Morning Stiffness:** **< 30 minutes** (ì§§ë‹¤. ì»¤í”¼ í•œ ì” ë§ˆì‹¤ ì‹œê°„ì´ë©´ í’€ë¦¼). â˜•ï¸\n### ğŸ§¬ Concept Update\n- ë‹¨ìˆœí•œ \"íƒ€ì´ì–´ ë§ˆëª¨\"ê°€ ì•„ë‹˜. ì—°ê³¨ ì„¸í¬(Chondrocyte)ê°€ ì†ìƒì„ ë³µêµ¬í•˜ë ¤ê³  íš¨ì†Œë„ ë‚´ê³  ì—¼ì¦ ë¬¼ì§ˆë„ ë‚´ëŠ” **Active Metabolic Process (ì‹¤íŒ¨í•œ ë³µêµ¬ ê³¼ì •)**ì„.\n- **Synovial Fluid:** **Non-inflammatory** (WBC 200 ~ 2,000). ë§‘ê±°ë‚˜ ì˜…ì€ í˜¸ë°•ìƒ‰.\n### âœ‹ Physical Exam (Hands)\n- **DIP Joint:** **Heberden's Nodes** (ì†ê°€ë½ ëë§ˆë”” íˆ­ íŠ€ì–´ë‚˜ì˜´).\n- **PIP Joint:** **Bouchard's Nodes** (ì¤‘ê°„ ë§ˆë””).\n- **CMC Joint:** ì—„ì§€ì†ê°€ë½ ë¿Œë¦¬ (Squaring of the thumb).\n- **Crucial Distinction:** **Spares the MCPs** (Knuckleì€ ì¹¨ë²” ì•ˆ í•¨. ì—¬ê¸°ê°€ ì•„í”„ë©´ RA ì˜ì‹¬!).\n### ğŸ’ Iron Overload Hint (Hemochromatosis)\n- ë§Œì•½ \"OA ê°™ì€ë°\" **2nd & 3rd MCP joint**ì— **Hook-like Osteophytes (ê°ˆê³ ë¦¬ ê°™ì€ ë¼ˆ ëŒê¸°)**ê°€ ë³´ì¸ë‹¤?\n- **Diagnosis:** **Hereditary Hemochromatosis** (ìœ ì „ì„± í˜ˆìƒ‰ì†Œì¹¨ì°©ì¦) ê°•ë ¥ ì˜ì‹¬! ğŸ§²\n### ğŸªœ Management (Step-up Approach)\n1. **Step 1 (Non-Pharm):** **Weight Loss & Exercise.** (ê°€ì¥ ì¤‘ìš”! â˜…)\n    - ì²´ì¤‘ 1kg ì¤„ì´ë©´ ë¬´ë¦ ì••ë ¥ 4kg ê°ì†Œ.\n    - Quadriceps strengthening (ëŒ€í‡´ì‚¬ë‘ê·¼ ê°•í™”) â†’ ê´€ì ˆ ì•ˆì •í™”.\n2. **Step 2 (Topical):** **Topical NSAIDs** (Diclofenac gel) - ì „ì‹  ë¶€ì‘ìš© ì ìŒ.\n3. **Step 3 (Oral):** **Oral NSAIDs** (Naproxen etc.) or **Duloxetine** (SNRI, ë§Œì„± í†µì¦ ì¡°ì ˆ).\n    - *Note:* Acetaminophen(Tylenol)ì€ ì´ì œ 1ì°¨ ì„ íƒì œê°€ ì•„ë‹˜ (íš¨ê³¼ ë¯¸ë¯¸).\n4. **Step 4 (End Stage):** **Total Joint Arthroplasty (ì¸ê³µê´€ì ˆ ì¹˜í™˜ìˆ )**. ì‚¶ì˜ ì§ˆì´ ë°”ë‹¥ì¼ ë•Œ.\n---\n## 6.0 Spondyloarthropathies (Seronegative) ğŸ§˜â€â™‚ï¸\n**\"The Inflammatory Back Pain.\"**\n### 6.1 Ankylosing Spondylitis (ê°•ì§ì„± ì²™ì¶”ì—¼) ğŸ‹\n- **Vignette:** ì Šì€ ë‚¨ì„± (<40ì„¸). ë§Œì„± í—ˆë¦¬ í†µì¦.\n- **Pain Pattern:** **Worse with Rest, Better with Exercise.** (OAì™€ ì •ë°˜ëŒ€!). ë°¤ì— ì•„íŒŒì„œ ê¹¸.\n- **Pathology:** **Enthesitis** (ì¸ëŒ€/í˜ì¤„ì´ ë¼ˆì— ë¶™ëŠ” ìë¦¬ì˜ ì—¼ì¦).\n- **Imaging:** sacroiliitis (ì²œì¥ê´€ì ˆì—¼) â†’ **Bamboo Spine** (ì²™ì¶”ê°€ ëŒ€ë‚˜ë¬´ì²˜ëŸ¼ êµ³ìŒ).\n- **Association:** **HLA-B27**. **Anterior Uveitis** (ëˆˆ ì¶©í˜ˆ, í†µì¦ - ì¦‰ì‹œ ì•ˆê³¼!).\n- **Treatment:** NSAIDs (1st line) â†’ ì‹¤íŒ¨í•˜ë©´ **TNF Inhibitors** (Infliximab, Etanercept). â†’ anti IL-17 (secukinumab)\n### 6.2 Reactive Arthritis (Reiter's Syndrome) ğŸ¦ \n- **Mnemonic:** **\"Can't see, can't pee, can't climb a tree.\"**\n    - Conjunctivitis/Uveitis (Can't see)\n    - Urethritis (Can't pee)\n    - Arthritis (Can't climb a tree)\n- **Trigger:** GI infection (Campylobacter, Salmonella, Shigella, Yersinia) or Chlamydia.\n---\n## 7.0 Vasculitis & Systemic Causes ğŸ©¸","subject":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","page_title":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","episode":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","section_path":["LM_OSRHM 30046f2986ee8098921dc4e04b63ee22"],"source_doc_id":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","source_page":null,"source_anchor":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22-81","focus_area":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","tags":["usmle-step2","core","diagnosis","treatment","mnemonic","tree"]}
{"chunk_type":"transcript_chunk","text":"### 7.1 Henoch-Schonlein Purpura (HSP) / IgA Vasculitis\n- **Patient:** ì£¼ë¡œ ì†Œì•„ (Pediatric).\n- **Tetrad:**\n    1. **Palpable Purpura:** ì—‰ë©ì´(Buttocks)ì™€ ë‹¤ë¦¬ ë’¤ìª½ì— ë§Œì ¸ì§€ëŠ” ìë°˜.\n    2. **Arthritis/Arthralgia:** ê´€ì ˆí†µ.\n    3. **Abdominal Pain:** ë°° ì•„í”” (Intussusception ìœ„í—˜). (Ileo-Ileal)\n    4. **Renal Disease:** **IgA Nephropathy** (í˜ˆë‡¨).\n### 7.2 Cryoglobulinemia â„ï¸\n- **Link:** **Hepatitis C (HCV)**ì™€ ê°•ë ¥í•œ ì—°ê´€ì„±.\n- **Mechanism:** ì°¨ê°€ìš´ ì˜¨ë„ì—ì„œ ë‹¨ë°±ì§ˆ(Cryoglobulins)ì´ ë­‰ì³ì„œ í˜ˆê´€ ë§‰ìŒ.\n- **Labs:** **Low C4**, Positive Rheumatoid Factor (RF), HCV RNA (+).\n    - cf. RFì–‘ì„±ì´ì—¬ë„ RAë©´ C4ì •ìƒì„. RFì–‘ì„±ì¸ë° C4ì •ìƒì´ë©´? â†’ HCV ê¸°ì™•ë ¥ í™•ì¸í•˜ê³  crygolobulinemiaì˜ì‹¬!\n- **Sx:** Palpable Purpura, Weakness, Arthralgias (Melted's Triad).\n---\n## 8.0 TMJ Dysfunction (Temporomandibular Joint) ğŸ¦·\n- **Symptom:** í„±ì—ì„œ \"ë”±ë”±\" ì†Œë¦¬(Clicking/Popping), ì”¹ì„ ë•Œ í†µì¦, ê·€ í†µì¦(Otalgia).\n- **Cause:** **Bruxism** (ì´ê°ˆì´), ìŠ¤íŠ¸ë ˆìŠ¤.\n- **Exam:** ì… ë²Œë¦´ ë•Œ í„± ê·¼ìœ¡ ì••í†µ, ì†Œë¦¬ í™•ì¸.\n- **Tx:** Conservative first! Soft diet (ë¶€ë“œëŸ¬ìš´ ìŒì‹), Night guard (ë§ˆìš°ìŠ¤í”¼ìŠ¤), NSAIDs.\n---\n## âš¡ï¸ RAPID FIRE RECAP (Summary Table)\n| **Condition** | **Key Vignette / Symptom** | **Synovial Fluid WBC** | **Gold Standard / Next Step** | **Treatment Highlights** |\n| --- | --- | --- | --- | --- |\n| **Septic Arthritis** | Red, Hot, Single Joint, **Refusal to move** | **> 50,000** (>90% PMN) | **Arthrocentesis** (Tap it!) | **IV Abx + Washout (Drainage)** |\n| **Gout** | Podagra (Big toe), sudden onset | 2,000 - 50,000 (Crystals) | Polarized Microscopy (Needle shape, Neg birefringent) | NSAIDs, Colchicine, Steroids (Acute) |\n| **OA** | Older, Worse with use, DIP/PIP involved | < 2,000 (Non-inflam) | X-ray (Joint space narrowing, Osteophytes) | **Weight Loss**, Exercise, NSAIDs |\n| **Fight Bite** | Cut on knuckle (MCP), punched mouth | N/A | History taking (Look for lie) | **Augmentin**, **NEVER SUTURE** |\n| **DGI** | Sexually active, Triad (Tenosynovitis, Rash, Polyarthralgia) | Often Negative culture | **NAAT** (Urethra, Rectum, Throat) | Ceftriaxone + Azithro/Doxy |\n| **Ankylosing Spondylitis** | Young male, Back pain better w/ exercise | N/A | X-ray (Sacroiliitis), HLA-B27 | NSAIDs â†’ TNF Inhibitors |\n| **HSP (IgA)** | Kid, Palpable purpura on butt, Abd pain | N/A | Clinical Dx, Urinalysis (Hematuria) | Supportive (Hydration, NSAIDs) |\n### ğŸ’¡ Final Wisdom\n**(Confidence: 1.0) - All content extracted from audio and structured for USMLE prep.**\n# ğŸ©º **USMLE Step 2 CK: Systemic Autoimmune Disorders Deep Dive**\n**(Rheumatoid Arthritis, SLE, Felty, MCTD)**\n---\n---","subject":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","page_title":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","episode":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","section_path":["LM_OSRHM 30046f2986ee8098921dc4e04b63ee22"],"source_doc_id":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","source_page":null,"source_anchor":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22-101","focus_area":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"### ğŸŒ³ **Big Picture: Classification & Mental Model**\nUSMLEì—ì„œ ë¥˜ë§ˆí‹°ìŠ¤í•™ì„ ì ‘ê·¼í•  ë•Œ ê°€ì¥ ì¤‘ìš”í•œ ê²ƒì€ **\"Pattern Recognition\"**ê³¼ **\"Antibody Correlation\"**ì…ë‹ˆë‹¤. ë‹¨ìˆœíˆ ê´€ì ˆì´ ì•„í”„ë‹¤ê°€ ì•„ë‹ˆë¼, ì–´ë–¤ íŒ¨í„´ìœ¼ë¡œ ì•„í”ˆì§€, ê·¸ë¦¬ê³  ì–´ë–¤ ì¥ê¸°ê°€ ê°™ì´ ë§ê°€ì§€ëŠ”ì§€ë¥¼ ë´ì•¼ í•©ë‹ˆë‹¤.\nPlaintext\n`SYSTEMIC AUTOIMMUNE DISORDERS (The \"Body attacking itself\")\nâ”‚\nâ”œâ”€â”€ JOINT-PREDOMINANT (Erosive)\nâ”‚   â””â”€â”€ Rheumatoid Arthritis (RA)\nâ”‚       â”œâ”€â”€ Key Path: Synovial Pannus (Inflammation)\nâ”‚       â”œâ”€â”€ Key Symptom: Morning Stiffness > 1hr (\"Gel Phenomenon\")\nâ”‚       â””â”€â”€ Complications:\nâ”‚           â”œâ”€â”€ Felty Syndrome (RA + Neutropenia + Splenomegaly)\nâ”‚           â””â”€â”€ C1-C2 Instability (Life Threatening!)\nâ”‚\nâ”œâ”€â”€ MULTI-SYSTEM (Vascultis/Organ Damage)\nâ”‚   â””â”€â”€ Systemic Lupus Erythematosus (SLE)\nâ”‚       â”œâ”€â”€ Key Path: Immune Complex Deposition (Type III)\nâ”‚       â”œâ”€â”€ Key Vibe: \"Fatigued Young Woman with Multiorgan Issues\"\nâ”‚       â”œâ”€â”€ Specifics: Malar Rash, Nephritis, Cerebritis\nâ”‚       â””â”€â”€ Variant: Drug-Induced Lupus (Histone Ab)\nâ”‚\nâ”œâ”€â”€ OVERLAP SYNDROMES\nâ”‚   â””â”€â”€ Mixed Connective Tissue Disease (MCTD)\nâ”‚       â”œâ”€â”€ Key Path: Features of SLE + Systemic Sclerosis + Polymyositis\nâ”‚       â””â”€â”€ Marker: Anti-U1-RNP\nâ”‚\nâ””â”€â”€ THROMBOTIC/OBSTETRIC\n    â””â”€â”€ Antiphospholipid Syndrome (APLA)\n        â”œâ”€â”€ Key Path: Hypercoagulable State\n        â””â”€â”€ Outcome: Clots (Arterial/Venous) + Pregnancy Loss`\n---\n![image.png](LM_OSRHM/image.png)\n- 50k ë„˜ìœ¼ë©´ septic joint arthritis until proven otherwise\n# 1. Rheumatoid Arthritis (RA) ğŸ¦´ğŸ”¥\n*The \"Morning Paralysis\" Disease*\n### ğŸšª **Doorway Thought (Vignette Anchor)**\n40-50ëŒ€ ì—¬ì„±ì´ ì•„ì¹¨ì— ì¼ì–´ë‚¬ëŠ”ë° ì¹¨ëŒ€ ëì— ê±¸í„°ì•‰ì•„ ìˆìŠµë‹ˆë‹¤. ë‹¨ìˆœíˆ í”¼ê³¤í•œ ê²Œ ì•„ë‹ˆë¼ **\"Gel Phenomenon\"** ë•Œë¬¸ì— ì›€ì§ì¼ ìˆ˜ê°€ ì—†ìŠµë‹ˆë‹¤. ì†ì´ ì‹œë©˜íŠ¸ì— êµ³ì€ ê²ƒì²˜ëŸ¼ ë»£ë»£í•˜ë©°, ì´ ì¦ìƒì´ **1ì‹œê°„ ì´ìƒ(>1hr)** ì§€ì†ë©ë‹ˆë‹¤.\n### ğŸ” **Clinical Features & \"The Vibe\"**\n- **Stiffness Duration:** â˜… **> 1 Hour** (ê°€ì¥ ì¤‘ìš”í•œ êµ¬ë³„ì ). OAëŠ” ë³´í†µ 15-30ë¶„ ì´ë‚´ì— í’€ë¦¼.\n- **Joint Pattern:**\n    - **Symmetric** (ëŒ€ì¹­ì ).\n    - **Small Joints:** MCP, PIP, Wrist ì¹¨ë²”.\n    - **SPARES DIP:** â˜… DIP(ì†ê°€ë½ ëë§ˆë””)ëŠ” ì¹¨ë²”í•˜ì§€ ì•ŠìŒ! (DIP ì¹¨ë²”ì€ OAì˜ Heberden's node).\n- **Texture:** ë§Œì ¸ë³´ë©´ **Soft, Warm, Boggy** (Sponge ê°™ìŒ). ë°˜ë©´ OAëŠ” Hard, Bonyí•¨.\n### ğŸ§ª **Diagnosis (Workup)**\n| **Lab Test** | **Sensitivity/Specificity** | **Notes** |\n| --- | --- | --- |\n| **RF (Rheumatoid Factor)** | Sensitive | ë¯¼ê°ë„ëŠ” ë†’ì§€ë§Œ íŠ¹ì´ë„ê°€ ë‚®ìŒ (ë‹¤ë¥¸ ë³‘ì—ì„œë„ ì–‘ì„± ê°€ëŠ¥). |\n| **Anti-CCP** | **Specific (Gold Standard)** | â˜… **ê°€ì¥ ì¤‘ìš”í•œ í™•ì§„ ê²€ì‚¬.** RAì— ë§¤ìš° íŠ¹ì´ì ì„. |\n| **ESR / CRP** | Inflammation Markers | ì§ˆë³‘ì˜ í™œì„±ë„(Activity)ë¥¼ ëª¨ë‹ˆí„°ë§í•˜ëŠ” ë° ìœ ìš©. |\n### âš ï¸ **Key Complications (High Yield)**\n1. **Lungs:** Pulmonary Nodules, Pleural Effusion, **Fibrosis (Interstitial Lung Disease)**.\n2. **Eyes:** **Scleritis** (Deep, boring eye PAINFUL - ì‘ê¸‰!), Episcleritis.\n3. **Heart:** Accelerated Atherosclerosis (ì‹¬í˜ˆê´€ ì§ˆí™˜ ìœ„í—˜ ê¸‰ì¦ -> MI, Stroke ì£¼ì˜).\n4. **Cervical Spine (C1-C2 Instability):** â˜… **USMLE KILLER QUESTION**\n    - C1-C2ë„ synovial joint.\n    - spinal compression â†’ UMN lesions â†’ weakness and spastic paralysis in all 4 limbs.\n        - ê°ê°ì´ ì•½í•´ì§€ê³ , ëª¸ì´ ì•½í•´ì§€ë©´ì„œ êµ³ì–´ìš”\n    - Hoffman sign to test UMN lesion: ê°€ìš´ë° ì†ê°€ë½ ì†í†±ì„ ì•„ë˜ë¡œ ë”¸ê¹í•˜ë©´, ì—„ì§€ì™€ ë‘ë²ˆì§¸ ì†ê°€ë½ì´ adduction, flexion.\n    - **Scenario:** RA í™˜ìê°€ ìˆ˜ìˆ (ì˜ˆ: ë‹´ë‚­ì ˆì œìˆ )ì„ ë°›ìœ¼ëŸ¬ ì˜´. ë§ˆì·¨ê³¼ ì˜ì‚¬ê°€ ì‚½ê´€(Intubation)ì„ ìœ„í•´ ê³ ê°œë¥¼ ë’¤ë¡œ ì –íˆë©´?\n    - **Risk:** Dens(Odontoid process)ê°€ ì²™ìˆ˜(Spinal cord)ë¥¼ ëˆŒëŸ¬ **ì‚¬ì§€ë§ˆë¹„(Quadriplegia)** í˜¹ì€ ì‚¬ë§ ìœ ë°œ.\n    - **Next Best Step:** ìˆ˜ìˆ  ì „ **Cervical Spine Flexion/Extension X-ray** í•„ìˆ˜!\n### ğŸ’Š **Treatment Strategy**\n- **Symptom Control:** NSAIDs, Steroids (Bridge therapy).\n- **DMARDs (Disease Modifying Anti-Rheumatic Drugs):**\n    - **Methotrexate (MTX):** â˜… **King of RA Treatment.** (First-line).\n        - *Mechanism:* Dihydrofolate reductase inhibitor (Folate antagonist).\n        - *Toxicities:* Hepatotoxicity, Stomatitis (ì…ì•ˆ í—ìŒ), **Bone Marrow Suppression**\n            - Pulmonary Fibrosis (Methotrexate induced lung injury)\n                - note: RAì— ì˜í•œ Pulmonary fibrosisë‘ êµ¬ë¶„í•´ì•¼ë¨. (RA: chronic slow scarring)\n                - Acute hypersensitivity reaction, therefore not dose dependent.\n                - Pneumoniaeì²˜ëŸ¼ ë³´ì„. fever, SOB.\n                - BAL: lymphocytosisê°€ ë³´ì„. Peripheral blood: eosinophilia\n        - *Prevention:* ë°˜ë“œì‹œ **Folate (Folic acid)**ë¥¼ ê°™ì´ ì²˜ë°©í•´ì•¼ í•¨!\n        - CIx: Renal, Hepatic disease, Pregnancy\n            - HBV, HCV í™˜ìì—ì„œ ê¸ˆê¸°. ë¯¸ë¦¬ ê²€ì‚¬í•´ì•¼ë¨.\n    - **Biologics:** Anti-TNF agents (Etanercept, Infliximab, Adalimumab).\n        - *Must Do:* ì‹œì‘ ì „ **TB Screening (Latent TB)**, Hep B/C Screening í•„ìˆ˜! (ì¬í™œì„±í™” ìœ„í—˜).\n    - Hydroxychloroquine: lupusë¿ì•„ë‹ˆë¼ RAì—ì„œë„ ë³´ì¡°ì¹˜ë£Œì •ë„ë¡œ ì•½í•œ í™˜ìì—ì„œ ì“°ì¼ ìˆ˜ ìˆìŒ.\n        - EYE damage ğŸ‘€Â ëˆˆì— ìŒ“ì„. Therefore, opthalmologic evaluation\n---","subject":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","page_title":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","episode":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","section_path":["LM_OSRHM 30046f2986ee8098921dc4e04b63ee22"],"source_doc_id":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","source_page":null,"source_anchor":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22-121","focus_area":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology","mnemonic"]}
{"chunk_type":"transcript_chunk","text":"# 2. Felty Syndrome ğŸ“‰ğŸ¦ \n*The \"Burned-Out\" RA Patient*\n### ğŸšª **Clinical Vignette**\nìˆ˜ì‹­ ë…„ê°„ RAë¥¼ ì•“ì•„ì˜¨ í™˜ì. ê´€ì ˆì€ ì´ë¯¸ ë‹¤ ë§ê°€ì ¸ì„œ ë’¤í‹€ë ¤ ìˆìŒ(**Erosive Arthritis**).\n*ê·¸ëŸ°ë° ì´ë²ˆì—” ê´€ì ˆí†µì´ ì•„ë‹ˆë¼ **ë°˜ë³µë˜ëŠ” ê°ì—¼(Pneumonia, Skin infection)**ìœ¼ë¡œ ë‚´ì›í•¨.*\n### âš¡ **The Triad (Must Memorize)**\n1. **Rheumatoid Arthritis** (Long-standing, severe).\n2. **Splenomegaly** (ë¹„ì¥ë¹„ëŒ€).\n3. **Neutropenia** (ANC < 2,000 - í˜¸ì¤‘êµ¬ ê°ì†Œ).\n# 3. Systemic Lupus Erythematosus (SLE) ğŸ¦‹ğŸº\n*The \"Great Imitator\" with a Migratory Pain*\n### ğŸšª **Doorway Thought (Vignette Anchor)**\n20-30ëŒ€ ì Šì€ ì—¬ì„±. ë‹¨ìˆœíˆ ê´€ì ˆë§Œ ì•„í”ˆ ê²Œ ì•„ë‹ˆë¼ **ê·¹ì‹¬í•œ í”¼ë¡œê°(Deep Fatigue)**ì„ í˜¸ì†Œí•¨. ì–¼êµ´ì—ëŠ” ë‚˜ë¹„ ëª¨ì–‘ ë°œì§„(**Malar Rash**)ì´ ìˆê³ , í–‡ë¹›ì„ ë°›ìœ¼ë©´ í”¼ë¶€ê°€ ë’¤ì§‘ì–´ì§(**Photosensitivity**).\n### ğŸ©º **Key Symptoms & Systemic Fire**\n- **Skin:** Malar Rash (â˜… **Spares Nasolabial Folds** - íŒ”ìì£¼ë¦„ì€ ì¹¨ë²” ì•ˆ í•¨!). Discoid Rash (Scarring ìœ ë°œ).\n- **Joints:** **Migratory â˜… Arthritis** (ëŒì•„ë‹¤ë‹ˆëŠ” í†µì¦)(RAë‘ ì°¨ì´)\nRAì™€ ë‹¬ë¦¬ **Non-erosive** (ë¼ˆë¥¼ ê°‰ì•„ë¨¹ì§€ ì•ŠìŒ). *Jaccoud Arthropathy* (ì†ê°€ë½ì´ íœ˜ì§€ë§Œ í´ë©´ í´ì§).\n- **Serositis:** Pleuritis (ìˆ¨ ì‰´ ë•Œ ì•„í””), Pericarditis.\n- **Heart:** Libman-Sacks Endocarditis (LSE) - \"Vegetations on **BOTH** sides of the valve\".\n- Pregnancy: 3rd trimester, protienuria, hypertension\n    - r/o Preeclampsia?â€¦?\n    - êµ¬ë¶„í•´ì•¼ ì¹˜ë£Œë¥¼ ê³ ë¦„. Steroid (SLE) vs delivery (preeclampsia)\n    - SLEì—ì„œëŠ” ICë¥¼ í˜•ì„±í•˜ê³  C3, C4 low. Preeclampsiaì—ì„œëŠ” ë³´ì²´ ì •ìƒ\n| in ğŸ¤° | SLE | Preeclampsia |\n| --- | --- | --- |\n| ë³´ì²´ | ê°ì†Œ\n(IC í˜•ì„±ìœ¼ë¡œ ì¸í•œ ë³´ì²´ ì†Œëª¨) | ì •ìƒ |\n| Urinalysis | Active inflammation\nâ†’ RBC cast | Cast ì—†ìŒ |\n| Tx. | Steroid | Delivery |\n### ğŸš¨ **Lupus Nephritis (The Silent Killer)**\n- ê°€ì¥ ì¤‘ìš”í•œ ì˜ˆí›„ ì¸ì. ì†Œë³€ì—ì„œ **Proteinuria**, Hematuria, **Casts** ë°œê²¬.\n- **Next Best Step:** â˜… **Renal Biopsy** (ì‹ ì¥ ì¡°ì§ê²€ì‚¬).\n    - *Why?* Lupus NephritisëŠ” Class I ~ VIê¹Œì§€ ë‹¨ê³„ê°€ ìˆê³ , ë‹¨ê³„ì— ë”°ë¼ ì¹˜ë£Œ(Steroid only vs. Cyclophosphamide/Mycophenolate)ê°€ ì™„ì „íˆ ë‹¬ë¼ì§. ë‹¨ìˆœíˆ ì†Œë³€ê²€ì‚¬ë§Œìœ¼ë¡œëŠ” ì¹˜ë£Œ ê²°ì •ì„ ë‚´ë¦´ ìˆ˜ ì—†ìŒ.\n### ğŸ§ª **Diagnosis (Antibodies)**\n| **Antibody** | **Characteristics** |\n| --- | --- |\n| **ANA (Anti-Nuclear Ab)** | **Sensitive (>95%)**. Screening Test. ìŒì„±ì´ë©´ SLE ì•„ë‹ í™•ë¥  ë†’ìŒ. |\n| **Anti-dsDNA** | **Specific**. â˜… **Disease Activityì™€ ë¹„ë¡€í•¨** (ìˆ˜ì¹˜ ë†’ìœ¼ë©´ ì‹ ì¥ì—¼ í™œì„±ë„ ë†’ìŒ). |\n| **Anti-Smith** | **Specific**. ì§ˆë³‘ í™œì„±ë„ì™€ëŠ” ë¬´ê´€í•˜ì§€ë§Œ ì§„ë‹¨ì  ê°€ì¹˜ ë†’ìŒ. |\n| **C3, C4 Levels** | **Low** in active flare. (ë³´ì²´ê°€ ë©´ì—­ë³µí•©ì²´ í˜•ì„±ì— ì†Œëª¨ë¨). |\n### ğŸ’Š **Drug-Induced Lupus**","subject":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","page_title":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","episode":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","section_path":["LM_OSRHM 30046f2986ee8098921dc4e04b63ee22"],"source_doc_id":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","source_page":null,"source_anchor":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22-141","focus_area":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","tags":["usmle-step2","core","diagnosis","treatment"]}
{"chunk_type":"transcript_chunk","text":"- **Culprit Drugs:** Hydralazine, Procainamide, Isoniazid, Quinidine. (\"SHIPP-E\" mnemonic).\n- **Antibody:** â˜… **Anti-Histone Antibody** (>95%).\n- **Difference:** ì‹ ì¥(Kidney)ê³¼ ë‡Œ(CNS) ì¹¨ë²”ì€ ë“œë¬¾. ì•½ ëŠìœ¼ë©´ ì¢‹ì•„ì§.\n- **Next Best Step:** Stop the offending drug.\n---\n# 4. Antiphospholipid Syndrome (APS) ğŸ©¸ğŸ¤°\n*Clots & Miscarriages*\n### ğŸšª **Clinical Vignette**\nì Šì€ ì—¬ì„± í™˜ìê°€ **ë°˜ë³µì ì¸ ìœ ì‚°(Recurrent Miscarriages)** í˜¹ì€ ì„¤ëª…ë˜ì§€ ì•ŠëŠ” **í˜ˆì „(DVT/PE/Stroke)** ë³‘ë ¥ì´ ìˆìŒ. PTTê°€ ì—°ì¥ë˜ì–´ ìˆëŠ”ë°(Paradoxical), í˜ˆì „ì´ ìƒê¹€.\n### âš¡ **Diagnostic Criteria**\n1. **Clinical:**\n    - Vascular Thrombosis (Arterial OR Venous).\n    - Pregnancy Morbidity\n        - 3+ unexplained losses <10w\n        - OR 1+ loss >10w\n        - OR severe preeclampsia/placental insufficiency).\n2. **Labs (CONSISTENT: Must be positive 2 times, 12 weeks apart):**\n    - **Lupus Anticoagulant** (False elevation of PTT).\n    - **Anticardiolipin Antibody** (Can cause False Positive VDRL/Syphilis test).\n    - **Anti-beta2-glycoprotein I.**\n### ğŸ’Š **Treatment**\n- **Non-Pregnant:** Warfarin (INR 2-3).\n- **Pregnant:** â˜… **LMWH (Low Molecular Weight Heparin) + Low Dose Aspirin**.\n    - *Note:* Warfarinì€ íƒœì•„ ê¸°í˜•(Teratogenic) ìœ ë°œí•˜ë¯€ë¡œ ì„ì‹  ì¤‘ ê¸ˆê¸°!\n---\n# 5. Mixed Connective Tissue Disease (MCTD) ğŸ§¤ğŸ”—\n*The \"Overlap\" Syndrome*\n### ğŸšª **Doorway Thought**\ní™˜ìê°€ ì™”ëŠ”ë° SLE ê°™ê¸°ë„ í•˜ê³ , Scleroderma(í”¼ë¶€ ê²½í™”) ê°™ê¸°ë„ í•˜ê³ , Polymyositis(ê·¼ìœ¡í†µ) ê°™ê¸°ë„ í•¨. ì†ì´ í‰í‰ ë¶€ì–´ìˆìŒ (**Puffy Hands / Sausage Digits**). ê·¸ë¦¬ê³  ì‹¬í•œ **Raynaud's Phenomenon**ì´ ìˆìŒ.\n### ğŸ§ª **The Golden Key**\n- **Anti-U1-RNP Antibody** (High Titer).\n- ì´ í•­ì²´ê°€ ì–‘ì„±ì´ë©´ì„œ SLE, Systemic Sclerosis, Polymyositisì˜ íŠ¹ì§•ì´ ì„ì—¬ ìˆìœ¼ë©´ MCTDë¡œ ì§„ë‹¨.\n---","subject":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","page_title":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","episode":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","section_path":["LM_OSRHM 30046f2986ee8098921dc4e04b63ee22"],"source_doc_id":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","source_page":null,"source_anchor":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22-161","focus_area":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","tags":["usmle-step2","core","treatment","mnemonic"]}
{"chunk_type":"recap_summary","text":"# ğŸ”¥ Rapid Fire Recap: Treatments & Side Effects\n| **Disease** | **Critical Drug** | **Major Side Effect / Note** |\n| --- | --- | --- |\n| **RA** | **Methotrexate** | Liver tox, Pulmonary fibrosis, **Marrow suppression**. Give **Folate**! |\n| **SLE (General)** | **Hydroxychloroquine** | **Retinopathy** (Eye toxicity). Annual Eye Exam í•„ìˆ˜! |\n| **SLE (Nephritis)** | Cyclophosphamide | Hemorrhagic cystitis (ë°©ê´‘ì—¼), Infertility. |\n| **Drug-Induced Lupus** | (Stop Drug) | Anti-Histone Ab Positive. |\n| **APS (Pregnant)** | **LMWH + Aspirin** | Warfarin is contraindicated. |\n| **RA Flare** | Prednisone | Osteoporosis, Hyperglycemia, Cataracts. |\n1. ê³ í˜ˆì•• ì•½ ë¨¹ë˜ í™˜ìê°€ ê´€ì ˆì´ ì•„íŒŒìš”\n    1. anti-histone ab? DILI. stop the drugs. Hydralazine\n2. ì†ê°€ë½ë¶€ì—ˆê³  Raynaudë„ ìˆê³  malar rashë„ ìˆê³  ê´€ì ˆí†µë„ ìˆê³ ? ì• ë§¤í•œ ì„ ë¬¼ì„¸íŠ¸\n    1. anti U1 RNPê²€ì‚¬! MCTD\n3. ì„ì‹ ì—¬ì„± ê³ í˜ˆì••, ë‹¨ë°±ë‡¨, ë³´ì²´ decreased\n    1. Lupus flare\n4. RAì˜¤ë˜ ì•“ì•˜ë˜ í™˜ìì—ì„œ ê°€ìš´ë° ì†ê°€ë½ ì†í†± ë”¸ê¹í–ˆë”ë‹ˆ ì—„ì§€ì™€ ê²€ì§€ê°€ ì›€ì°”\n    1. Hoffman sign â†’ UMN lesion, cervical myelopathy\n5. RAì˜¤ë˜ ì•“ì•˜ë˜ í™˜ìì—ì„œ ê³„ì† ê°ì—¼ì´ ìƒê¸°ê³  ì™¼ìª½ë°°ê°€ ë¶ˆëŸ¬ì˜¤ë¦„(splenomegaly). í”¼ê²€ì‚¬ì—ì„œ í™•ì¸í•´ì•¼í•  ìˆ«ì\n    1. ANC<2000\n6. ì–´ë–¤ ë¥˜ë§ˆ ì•½ì´ ë¨¹ì€ì§€ 5ë…„í›„ë¶€í„° ì•ˆê³¼ê²€ì§„ ë§¤ë…„í•´ì•¼í•˜ëŠ”ì§€?\n    1. Hydroxychloroquine\n7. Lupusí™˜ìì—ì„œ ë‹¨ë°±ë‡¨ Next Step?\n    1. Renal biopsy\n---\n- **Septic Arthritis vs RA Flare:** WBC > 50,000 in joint fluid = **Septic**. (Medical Emergency! Antibiotics & Drainage). RA flareëŠ” ë³´í†µ 2,000 ~ 50,000 ì‚¬ì´.\n- **Lupus Nephritis:** ì†Œë³€ ê²€ì‚¬ ì´ìƒí•˜ë©´ ë¬´ì¡°ê±´ **Biopsy**. ì¶”ì¸¡ìœ¼ë¡œ ì¹˜ë£Œí•˜ì§€ ë§ ê²ƒ.\n- **RA Cervical Spine:** ìˆ˜ìˆ  ì „ ëª© ì—‘ìŠ¤ë ˆì´ ì•ˆ ì°ì–´ì„œ í™˜ì ë§ˆë¹„ì‹œí‚¤ë©´ ì‹œí—˜ ë–¨ì–´ì§(ê·¸ë¦¬ê³  í™˜ìëŠ” ë¶ˆí–‰í•´ì§). ğŸ’€\n### Overview: Systemic Autoimmune Disorders Part 2 (TL;DR)\nì´ë²ˆ ì—í”¼ì†Œë“œëŠ” ë¥˜ë§ˆí‹°ìŠ¤í•™(Rheumatology)ì˜ ê±°ëŒ€í•œ ë‘ ì‚°ë§¥ì¸ **ì²™ì¶”ê´€ì ˆë³‘ì¦(Spondyloarthropathies)**ê³¼ **ê²°í•©ì¡°ì§ì§ˆí™˜(Connective Tissue Diseases)**ì„ ë‹¤ë£¹ë‹ˆë‹¤. USMLE Step 2 CK ë° ì„ìƒì—ì„œ ìƒëª…ì„ ìœ„í˜‘í•˜ëŠ” í•©ë³‘ì¦(Renal crisis ë“±)ì„ ë†“ì¹˜ì§€ ì•Šê¸° ìœ„í•œ íŒ¨í„´ ì¸ì‹(Pattern Recognition)ì— ì§‘ì¤‘í•©ë‹ˆë‹¤.\n- **Group 1: Seronegative Spondyloarthropathies (SpA)**\n    - íŠ¹ì§•: RF Negative, HLA-B27 ì—°ê´€, ì²™ì¶”/enthesitis ì¹¨ë²”.\n    - ì§ˆí™˜: ê°•ì§ì„± ì²™ì¶”ì—¼(AS), ë°˜ì‘ì„± ê´€ì ˆì—¼(ReA), ê±´ì„  ê´€ì ˆì—¼(PsA).\n- **Group 2: Connective Tissue Heavy Hitters**\n    - ì§ˆí™˜: ì‡¼ê·¸ë Œ ì¦í›„êµ°(Sjogren's), ì „ì‹  ê²½í™”ì¦(Scleroderma - Limited vs Diffuse), ë ˆì´ë…¸ í˜„ìƒ(Raynaud's).\n---","subject":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","page_title":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","episode":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","section_path":["LM_OSRHM 30046f2986ee8098921dc4e04b63ee22"],"source_doc_id":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","source_page":null,"source_anchor":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22-179","focus_area":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","tags":["usmle-step2","core","recap","diagnosis","treatment"]}
{"chunk_type":"transcript_chunk","text":"### 1. Top-Down Classification & Big Picture (ASCII Tree) ğŸŒ³\n**Mental Model:**\nì´ íŒŒíŠ¸ëŠ” í¬ê²Œ \"ì²™ì¶”ì™€ ê´€ì ˆì— ì—¼ì¦ì´ ìƒê¸°ëŠ” ê·¸ë£¹(SpA)\"ê³¼ \"í”¼ë¶€ì™€ ì¥ê¸°ê°€ ë”±ë”±í•´ì§€ê±°ë‚˜ ë§ˆë¥´ëŠ” ê·¸ë£¹(Connective Tissue)\"ìœ¼ë¡œ ë‚˜ë‰©ë‹ˆë‹¤.\n- **SpA:** 'Seronegative'ë¼ëŠ” ë§ì€ ë¥˜ë§ˆí‹°ìŠ¤ ì¸ì(RF)ê°€ ì—†ë‹¤ëŠ” ëœ»ì´ì§€, ë³‘ì´ ê°€ë³ë‹¤ëŠ” ëœ»ì´ ì•„ë‹™ë‹ˆë‹¤. ì´ë“¤ì€ **HLA-B27** ìœ ì „ìì™€ ê°•ë ¥í•œ family tieë¥¼ ê°€ì§‘ë‹ˆë‹¤.\n- **Connective Tissue:** ì„¬ìœ í™”(Fibrosis)ì™€ ê±´ì¡°(Dryness)ê°€ í•µì‹¬ì…ë‹ˆë‹¤. íŠ¹íˆ **Scleroderma Renal Crisis**ëŠ” ë‚´ê³¼ì  ì‘ê¸‰ìƒí™©(Emergency)ì„ì„ ëª…ì‹¬í•´ì•¼ í•©ë‹ˆë‹¤.\nPlaintext\n`Systemic Autoimmune Disorders (Part 2)\nâ”‚\nâ”œâ”€â”€ Seronegative Spondyloarthropathies (SpA) [RF(-), HLA-B27(+)]\nâ”‚   â”œâ”€â”€ Ankylosing Spondylitis (AS) : ëŒ€ë‚˜ë¬´ ì²™ì¶”, ì—¼ì¦ì„± ë“±í†µì¦\nâ”‚   â”œâ”€â”€ Reactive Arthritis (ReA)    : ê°ì—¼ í›„ ë°œìƒ, Can't see/pee/climb\nâ”‚   â””â”€â”€ Psoriatic Arthritis (PsA)   : ê±´ì„ , ì†Œì‹œì§€ ì†ê°€ë½, DIP ê´€ì ˆ\nâ”‚\nâ””â”€â”€ Connective Tissue Diseases (Fibrosis & Dryness)\n    â”œâ”€â”€ Sjogren's Syndrome          : Sicca sx, ë¦¼í”„ì¢… ìœ„í—˜(â˜…)\n    â”œâ”€â”€ Systemic Sclerosis (Scleroderma)\n    â”‚   â”œâ”€â”€ Limited (CREST)         : Anti-Centromere, PAH ìœ„í—˜\n    â”‚   â””â”€â”€ Diffuse                 : Anti-Scl-70, ILD & Renal Crisis(â˜…)\n    â””â”€â”€ Raynaud's Phenomenon        : í˜ˆê´€ ì—°ì¶• (Whiteâ†’Blueâ†’Red)`\n---\n### 2. Seronegative Spondyloarthropathies (SpA) ğŸ¦´\nì´ ê·¸ë£¹ì˜ ì´ë¦„ì´ 'Seronegative'ì¸ ì´ìœ ëŠ” **Rheumatoid Factor (RF)**ê°€ ìŒì„±ì´ê¸° ë•Œë¬¸ì…ë‹ˆë‹¤. í•˜ì§€ë§Œ ìœ ì „ì ìœ¼ë¡œ **HLA-B27 (MHC Class I allele)**ê³¼ ì•„ì£¼ ê°•ë ¥í•˜ê²Œ ì—°ê²°ë˜ì–´ ìˆìŠµë‹ˆë‹¤.\n### A. Ankylosing Spondylitis (AS, ê°•ì§ì„± ì²™ì¶”ì—¼)\n**ğŸšª Doorway Thought (Vignette Anchor):**\n40ì„¸ ë¯¸ë§Œì˜ ì Šì€ ë‚¨ì„±. ë§Œì„±ì ì¸ ìš”í†µ(Low back pain)ì„ í˜¸ì†Œí•˜ëŠ”ë°, **\"ì¶•êµ¬í•˜ê±°ë‚˜ ë›¸ ë•ŒëŠ” ê´œì°®ì€ë°, ìë ¤ê³  ëˆ„ìš°ë©´ ì•„íŒŒì„œ ê¹¬ë‹¤\"**ê³  í•¨. ì•„ì¹¨ì— ì¼ì–´ë‚˜ë©´ ë»£ë»£í•¨(Stiffness)ì´ 30ë¶„ ì´ìƒ ì§€ì†ë¨.\n- **í•µì‹¬ êµ¬ë³„ì : Inflammatory vs. Mechanical Pain**\n| **Feature** | **Inflammatory Back Pain (AS)** | **Mechanical Back Pain (Herniated Disc, OA)** |\n| --- | --- | --- |\n| **Activity** | ìš´ë™í•˜ë©´ í˜¸ì „ë¨ (Improves with exercise) | ì›€ì§ì´ë©´ ë” ì•„í”” (Worse with movement) |\n| **Rest/Sleep** | ì‰´ ë•Œ/ì˜ ë•Œ ì•…í™” (Worse with rest) | ì‰¬ë©´ ì¢‹ì•„ì§ (Better with rest) |\n| **Morning Stiffness** | > 30ë¶„ ì§€ì† | ì§§ê²Œ ì§€ë‚˜ê° |\n| **Cause** | ì—¼ì¦ ë¬¼ì§ˆ ì¶•ì  (Inflammatory mediators) | êµ¬ì¡°ì /ë¬¼ë¦¬ì  ì••ë°• |\n- **Clinical Features:**\n    - **Enthesitis (ë¶€ì°©ë¶€ì—¼):** ì¸ëŒ€ë‚˜ í˜ì¤„ì´ ë¼ˆì— ë¶™ëŠ” ìë¦¬ì— ì—¼ì¦. **Achilles tendon** í†µì¦ì´ í´ë˜ì‹í•œ ì˜ˆì‹œ. (ë°œë’¤ê¿ˆì¹˜ ì•„í”„ë‹¤ê³  í•˜ë©´ AS ì˜ì‹¬!)\n    - **Uveitis (í¬ë„ë§‰ì—¼):** ì¶©í˜ˆë˜ê³  ì•„í”ˆ ëˆˆ(Red, painful, photophobic eye). ê°€ì¥ í”í•œ ê´€ì ˆ ì™¸ ì¦ìƒ.\n    - **Bamboo Spine:** ì²™ì¶”ì˜ ì—¼ì¦ì´ ìœµí•©(Fusion)ìœ¼ë¡œ ì´ì–´ì ¸ ëŒ€ë‚˜ë¬´ì²˜ëŸ¼ ë»£ë»£í•´ì§. ê³¨ì ˆ ìœ„í—˜ ì¦ê°€.\n    - **Cardiovascular:** Aortic Regurgitation (ëŒ€ë™ë§¥íŒ ì—­ë¥˜), Conduction defect.\n    - Cauda equina: bladder, bowel problems.\n- **Diagnosis (ì§„ë‹¨):**\n    - **â˜… Best Initial Step:** X-ray of Sacroiliac joints (Sacroiliitis í™•ì¸ - Erosions, Sclerosis).\n    - **â˜… Most Sensitive/Early Detection:** **MRI**. (X-rayê°€ ì •ìƒì´ì§€ë§Œ ì˜ì‹¬ë  ë•Œ).\n        - *Note:* HLA-B27 ê²€ì‚¬ëŠ” ì§„ë‹¨ì ì´ì§€ ì•ŠìŒ (ì¸êµ¬ì˜ ë§ì€ ì‚¬ëŒì´ ì–‘ì„±ì´ë¯€ë¡œ).\n- **Treatment (ì¹˜ë£Œ):**\n    - **â˜… First Line:** **NSAIDs** (Indomethacin, Naproxen ë“±). ìš´ë™ ìš”ë²•.\n    - **â˜… If NSAIDs Fail:** **TNF-alpha Inhibitors** (Etanercept, Infliximab, Adalimumab). ì§ˆë³‘ ì§„í–‰ì„ ëŠ¦ì¶œ ìˆ˜ ìˆìŒ.\n        - *ì£¼ì˜:* ìŠ¤í…Œë¡œì´ë“œëŠ” ì²™ì¶” ì¦ìƒì— í° íš¨ê³¼ ì—†ìŒ.\n### B. Reactive Arthritis (ReA, ë°˜ì‘ì„± ê´€ì ˆì—¼)\n**ğŸšª Doorway Thought:**\n**\"Can't see, can't pee, can't climb a tree.\"** (ëˆˆ, ì†Œë³€, ê´€ì ˆ ë¬¸ì œ). ìµœê·¼ì— ë°°íƒˆì´ ë‚¬ê±°ë‚˜(Food poisoning) ìƒˆë¡œìš´ íŒŒíŠ¸ë„ˆì™€ ì„±ê´€ê³„(Chlamydia)ê°€ ìˆì—ˆë˜ ì Šì€ í™˜ì.\n- **Triggers (ê°ì—¼ì›):** ê°ì—¼ í›„ 1~4ì£¼ ë’¤ ë°œìƒ.\n    1. **Genitourinary:** *Chlamydia trachomatis* (ê°€ì¥ í”í•¨).\n    2. **Gut (Enteritis):** *Salmonella, Shigella, Yersinia, Campylobacter, Clostridioides (C.diff)*.\n- **Symptoms:**\n    - **Conjunctivitis / Uveitis** (Can't see)\n    - **Urethritis** (Can't pee)\n    - **Arthritis** (Can't climb a tree) - ì£¼ë¡œ í•˜ì§€ì˜ ë¹„ëŒ€ì¹­ì  ê´€ì ˆì—¼ (Knee, Ankle).\n    - **â˜… Dermatologic:**\n        - **Keratoderma blennorrhagicum:** ë°œë°”ë‹¥ì´ë‚˜ ì†ë°”ë‹¥ì— ìƒê¸°ëŠ” ì™ìŠ¤ ê°™ì€(waxy), ìˆ˜í¬ ê°™ì€ ë³‘ë³€.\n        - **Circinate balanitis:** ê·€ë‘(glans penis)ì— ìƒê¸°ëŠ” ë°œì§„.\n- **Treatment:** NSAIDs (1st line). ê°ì—¼ì´ ë‚¨ì•„ìˆë‹¤ë©´ í•­ìƒì œ ì¹˜ë£Œ (Chlamydia ë“±).","subject":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","page_title":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","episode":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","section_path":["LM_OSRHM 30046f2986ee8098921dc4e04b63ee22"],"source_doc_id":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","source_page":null,"source_anchor":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22-189","focus_area":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","tags":["usmle-step2","core","diagnosis","treatment","mnemonic","tree"]}
{"chunk_type":"transcript_chunk","text":"### C. Psoriatic Arthritis (PsA, ê±´ì„  ê´€ì ˆì—¼)\n**ğŸšª Doorway Thought:**\nê±´ì„ (Psoriasis) í”¼ë¶€ ë³‘ë³€ì´ ìˆëŠ” í™˜ìê°€ ê´€ì ˆí†µì„ í˜¸ì†Œ. í˜¹ì€ ì†í†±ì´ ì´ìƒí•¨.\n- **Key Features:**\n    - **Dactylitis:** **\"Sausage Digits\"**. ì†ê°€ë½/ë°œê°€ë½ ì „ì²´ê°€ ì†Œì‹œì§€ì²˜ëŸ¼ ë¶€ì–´ì˜¤ë¦„.\n    - **DIP Involvement:** ì†ê°€ë½ ëë§ˆë””(Distal Interphalangeal joint) ì¹¨ë²”ì´ íŠ¹ì§•ì  (RAëŠ” ë³´í†µ DIPë¥¼ ì¹¨ë²”í•˜ì§€ ì•ŠìŒ!).\n    - **Nail Changes:** Nail pitting (ë°”ëŠ˜ë¡œ ì½•ì½• ì°Œë¥¸ ë“¯í•œ í•¨ëª°), Onycholysis (ì†í†±ì´ ë“¤ëœ¸).\n- ê±´ì„  í”¼ë¶€ í™˜ì ì§ˆí™˜ì´ ë‚˜íƒ€ë‚˜ê¸°ì „ì—ë„ ê±´ì„  ê´€ì ˆì—¼ë¶€í„° ë¨¼ì € ë‚˜íƒ€ë‚  ìˆ˜ ìˆìŒ.\n    - nail pitting, familial history of Psoriasis, DIP patternâ€¦ìœ¼ë¡œ ì˜ì‹¬.\n---\n### 3. Connective Tissue Diseases ğŸ§¬\nì„¬ìœ í™”(Fibrosis)ì™€ ìê°€ë©´ì—­ì„± ì—¼ì¦ì´ íŠ¹ì§•ì…ë‹ˆë‹¤.\n### A. Sjogren's Syndrome (ì‡¼ê·¸ë Œ ì¦í›„êµ°)\n**ğŸšª Doorway Thought:**\n40-60ëŒ€ ì—¬ì„±. **\"ëˆˆì´ ëª¨ë˜ ë“¤ì–´ê°„ ê²ƒì²˜ëŸ¼ ë»‘ë»‘í•´ìš”(Gritty)\"**, **\"ë¬¼ ì—†ì´ëŠ” í¬ë˜ì»¤ë¥¼ ëª» ì‚¼í‚¤ê² ì–´ìš”(Cracker Sign)\"**.\n- **Pathophysiology:** Exocrine glands (ì¹¨ìƒ˜, ëˆˆë¬¼ìƒ˜)ë¥¼ ë¦¼í”„êµ¬(Lymphocyte)ê°€ ê³µê²©í•˜ì—¬ íŒŒê´´í•¨.\n- **Diagnosis:**\n    - **Antibodies:** Anti-Ro (SSA) & Anti-La (SSB).\n    - **Tests:** Schirmer test (ëˆˆë¬¼ ì–‘ ì¸¡ì • - ì¢…ì´ ë  ì´ìš©).\n    - **â˜… Gold Standard:** **Lip Biopsy** (Minor salivary glandì—ì„œ Focal lymphocytic sialadenitis í™•ì¸).\n- **âš ï¸ WARNING: The Scary Complication**\n    - ì‡¼ê·¸ë Œ í™˜ìê°€ ê°‘ìê¸° ë¦¼í”„ì ˆì´ ë¶“ê±°ë‚˜(Lymphadenopathy), ì²´ì¤‘ì´ ë¹ ì§€ë©´?\n    - **â˜… Non-Hodgkin Lymphoma (B-cell Lymphoma)** ë°œìƒ ìœ„í—˜ì´ ë§¤ìš° ë†’ìŒ (MALT lymphoma). ì¦‰ì‹œ malignancy workupì„ í•´ì•¼ í•¨!\n- ëŠ™ì–´ì„œ ëˆˆë¬¼ì´ ì•ˆë‚˜ì˜¤ëŠ” Age-related dry eye syndromeê³¼ì˜ ë¹„êµ\n    - Normal ESR, Normal Schimmer test\n### B. Systemic Sclerosis (Scleroderma, ì „ì‹  ê²½í™”ì¦)\n**ì„¸ê°€ì§€! â˜…  â‘  í˜ˆê´€ì´ ì†ìƒë˜ê³  â‘¡ ë©´ì—­ ê³¼í™œì„±í™” â‘¢  í”¼ë¶€ê°€ ë‘êº¼ì›Œì§€ê³  ë”±ë”±í•´ì§€ëŠ” ë³‘.**\në²”ìœ„ì— ë”°ë¼ ë‘ ê°€ì§€ë¡œ ë‚˜ë‰©ë‹ˆë‹¤.\n| **Feature** | **Limited Cutaneous (CREST)** | **Diffuse Cutaneous** |\n| --- | --- | --- |\n| **Skin Involvement** | ì–¼êµ´, ì†, ë°œ (Distal extremities only) | íŒ”, ë‹¤ë¦¬, ëª¸í†µ (Proximal extremities & Trunk) |\n| **Progression** | ëŠë¦¼ (Slow) | ë¹ ë¦„ (Rapid) |\n| **Antibody** | **Anti-Centromere** | **Anti-Scl-70 (Anti-topoisomerase I)** |\n| **Internal Organ** | Pulmonary Arterial Hypertension (PAH) | Interstitial Lung Disease (ILD), **Renal Crisis** |\n| **Prognosis** | ìƒëŒ€ì ìœ¼ë¡œ ì–‘í˜¸ | ë‚˜ì¨ (ì‹¬ê°í•œ ì¥ê¸° ì¹¨ë²”) |\n- **Limited Scleroderma (CREST Syndrome):**\n    - **C**alcinosis (í”¼ë¶€ ë°‘ ì¹¼ìŠ˜ ì¹¨ì°©)\n    - **R**aynaud's phenomenon\n    - **E**sophageal dysmotility (GERD, Heartburn - í•˜ë¶€ ì‹ë„ê°€ ë”±ë”±í•´ì§)\n    - **S**clerodactyly (ì†ê°€ë½ í”¼ë¶€ ê²½í™”)\n    - **T**elangiectasia (ëª¨ì„¸í˜ˆê´€ í™•ì¥)\n- **â˜… Scleroderma Renal Crisis (SRC) - The Emergency ğŸš¨**\n    - **Situation:** Diffuse type í™˜ìê°€ ê°‘ìê¸° ë‘í†µ, ì‹œì•¼ íë¦¼ ë“±ì„ í˜¸ì†Œ. BP 200/110. Acute Kidney Injury (Cr ìƒìŠ¹).\n    - **Mechanism:** ì‹ ì¥ í˜ˆê´€ì´ ì¢ì•„ì§ â†’ ì‹ ì¥ì´ \"í”¼ê°€ ì•ˆ ì˜¨ë‹¤!\"ê³  ì˜¤í•´ â†’ **Renin-Angiotensin System í­ë°œ** â†’ í˜ˆì•• ê¸‰ìƒìŠ¹ â†’ í˜ˆê´€ ë” ë§ê°€ì§ (ì•…ìˆœí™˜).\n    - **Findings:** MAHA (Microangiopathic Hemolytic Anemia) - Schistocytes, Low platelets.\n    - **â˜… Treatment (Gold Standard):** **ACE Inhibitors (e.g., Captopril)**.\n        - ë‹¤ë¥¸ hypertensive emergencyì—ì„œì²˜ëŸ¼ BB ë¥¼ ì“°ëŠ”ê²Œ ì•„ë‹˜.\n        - ì´ê²ƒì€ Renin í­ë°œì„ ë§‰ëŠ” ìœ ì¼í•œ ë°©ë²•. í¬ë ˆì•„í‹°ë‹Œì´ ì˜¬ë¼ë„ ACEi, ARBë¥¼ ì¨ì•¼ í•¨(Life-saving).\n    - **â›”ï¸ CONTRAINDICATION:** **Beta-blockers** (í˜ˆê´€ ìˆ˜ì¶•ì„ ì•…í™”ì‹œí‚¬ ìˆ˜ ìˆìœ¼ë¯€ë¡œ ì ˆëŒ€ ê¸ˆê¸°!).\n### C. Raynaud's Phenomenon (ë ˆì´ë…¸ í˜„ìƒ)\n**ğŸšª Doorway Thought:**\nì¶”ìœ„ë‚˜ ìŠ¤íŠ¸ë ˆìŠ¤ì— ë…¸ì¶œë˜ë©´ ì†ê°€ë½ ìƒ‰ê¹”ì´ ë³€í•¨.\n**White (Ischemia) â†’ Blue (Hypoxia) â†’ Red (Reperfusion)**.","subject":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","page_title":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","episode":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","section_path":["LM_OSRHM 30046f2986ee8098921dc4e04b63ee22"],"source_doc_id":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","source_page":null,"source_anchor":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22-209","focus_area":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology"]}
